ALX-1393 TFA is a selective glycine transporter-2 (GlyT2) inhibitor that demonstrates an antinociceptive effect, meaning it helps reduce pain. This compound has been observed to alleviate pain responses to thermal, mechanical, and chemical stimulations in a rat acute pain model. In experimental settings, administration of the compound has been shown to suppress the late-phase response in the formalin test and inhibit mechanical and cold hyperalgesia in a dose-dependent manner, without affecting motor performance in normal rats.
- Selectively inhibits a specific neuronal transporter.
- Exhibits pain-reducing effects across various types of pain stimuli.
- Effective in inflammatory and neuropathic pain models.
- Does not impair motor function.